Column Capital Advisors’s Guardant Health GH Stock Holding History

Column Capital Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-200	Closed	-$11K	–	847
2022 Q3	$11K	Hold	200	–	–	﹤0.01%	455
2022 Q2	$8K	Hold	200	–	–	﹤0.01%	506
2022 Q1	$13K	Hold	200	–	–	﹤0.01%	462
2021 Q4	$20K	Hold	200	–	–	﹤0.01%	411
2021 Q3	$25K	Hold	200	–	–	0.01%	361
2021 Q2	$25K	Hold	200	–	–	0.01%	359
2021 Q1	$31K	Hold	200	–	–	0.01%	331
2020 Q4	$26K	Hold	200	–	–	0.01%	358
2020 Q3	$22K	Hold	200	–	–	0.01%	352
2020 Q2	$16K	Hold	200	–	–	0.01%	407
2020 Q1	$14K	Hold	200	–	–	0.01%	355
2019 Q4	$15K	Buy	+200	New	+$14.4K	0.01%	400

Other funds holding GH

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return